Kathy Oubre. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antineoplastic Agents/economicsAntineoplastic Agents/therapeutic useBiosimilar Pharmaceuticals/economicsBiosimilar Pharmaceuticals/therapeutic useCost ControlDrug CostsEmpowermentHumansNeoplasms/drug therapyNeoplasms/economicsPhysicians
Substances: See more » Antineoplastic AgentsBiosimilar Pharmaceuticals
Year: 2019 PMID: 31860250
Source DB: PubMed Journal: Am J Manag Care ISSN: 1088-0224 Impact factor: 2.229